TSR (TSRI) 10-Q 15 Apr 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Feb. 29, 2024	Apr. 15, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Feb. 29, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Information [Line Items]
Entity Registrant Name	TSR, Inc.
Entity Central Index Key	0000098338
Entity File Number	001-38838
Entity Tax Identification Number	13-2635899
Entity Incorporation, State or Country Code	DE
Current Fiscal Year End Date	--05-31
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	400 Oser Avenue
Entity Address, Address Line Two	Suite 150
Entity Address, City or Town	Hauppauge
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11788
Entity Phone Fax Numbers [Line Items]
City Area Code	631
Local Phone Number	231-0333
Entity Listings [Line Items]
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	TSRI
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		2,169,546

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Feb. 29, 2024	May 31, 2023
Current Assets:
Cash and cash equivalents	$ 10,627,178	$ 7,382,320
Certificates of deposit and marketable securities	34,440	515,152
Accounts receivable, net of allowance for doubtful accounts of $181,000	10,535,128	12,081,335
Other receivables	53,435	79,618
Prepaid expenses	435,245	248,534
Total Current Assets	21,685,426	20,306,959
Equipment and leasehold improvements, net of accumulated depreciation and amortization of $314,849 and $270,606, respectively	25,356	69,599
Other assets	31,761	48,772
Right-of-use assets	620,391	459,171
Intangible assets, net	1,219,000	1,333,500
Goodwill	785,883	785,883
Deferred income taxes	279,000	344,000
Total Assets	24,646,817	23,347,884
Current Liabilities:
Accounts payable and other payables	1,624,144	1,663,990
Accrued expenses and other current liabilities	3,941,990	3,663,326
Advances from customers	588,496	1,266,993
Income taxes payable	93,867	11,260
Operating lease liabilities - current	188,592	150,167
Total Current Liabilities	6,437,089	6,755,736
Operating lease liabilities, net of current portion	461,478	342,260
Total Liabilities	6,898,567	7,097,996
Commitments and contingencies
Equity:
Preferred stock, $1 par value, authorized 500,000 shares; none issued
Common stock, $.01 par value, authorized 12,500,000 shares; issued 3,348,361 and 3,322,527 shares, 2,169,546 and 2,143,712 shares outstanding, respectively	33,484	33,226
Additional paid-in capital	7,755,331	7,676,742
Retained earnings	23,629,972	22,212,107
Shareholder's equity before treasury stock	31,418,787	29,922,075
Less: Treasury stock, 1,178,815 shares, at cost	13,726,895	13,726,895
Total TSR, Inc. Equity	17,691,892	16,195,180
Noncontrolling interest	56,358	54,708
Total Equity	17,748,250	16,249,888
Total Liabilities and Equity	$ 24,646,817	$ 23,347,884

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)	Feb. 29, 2024	May 31, 2023
Statement of Financial Position [Abstract]
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	$ 181,000	$ 181,000
Net of accumulated depreciation and amortization (in Dollars)	$ 314,849	$ 270,606
Preferred stock, par value (in Dollars per share)	$ 1	$ 1
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued
Common stock par value (in Dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	12,500,000	12,500,000
Common stock, shares issued	3,348,361	3,322,527
Common stock, shares outstanding	2,169,546	2,143,712
Treasury stock, shares	1,178,815	1,178,815

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Income Statement [Abstract]
Revenue, net	$ 19,702,992	$ 24,257,167	$ 63,873,759	$ 76,487,411
Cost of sales	16,372,675	20,267,337	52,698,669	63,433,855
Selling, general and administrative expenses	3,367,759	3,768,902	9,804,624	11,071,679
Cost and expenses, total	19,740,434	24,036,239	62,503,293	74,505,534
Income (loss) from operations	(37,442)	220,928	1,370,466	1,981,877
Other income (expense):
Interest income (expense), net	28,412	(9,069)	52,188	(44,907)
Reversal of advances from customers	547,318		547,318
Unrealized gain (loss) on marketable securities, net	(1,320)	(4,112)	9,288	(15,592)
Income before income taxes	536,968	207,747	1,979,260	1,921,378
Provision for income taxes	110,000	110,000	494,000	629,000
Consolidated net income	426,968	97,747	1,485,260	1,292,378
Less: Net income attributable to noncontrolling interest	15,876	18,107	67,395	44,159
Net income attributable to TSR, Inc.	$ 411,092	$ 79,640	$ 1,417,865	$ 1,248,219
Basic net income per TSR, Inc. common share (in Dollars per share)	$ 0.19	$ 0.04	$ 0.66	$ 0.58
Diluted net income per TSR, Inc. common share (in Dollars per share)	$ 0.19	$ 0.04	$ 0.66	$ 0.56
Basic weighted average number of common shares outstanding (in Shares)	2,152,323	2,134,660	2,146,551	2,140,344
Diluted weighted average number of common shares outstanding (in Shares)	2,152,323	2,234,600	2,146,551	2,235,173

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)	Common stock	Additional paid-in capital	Retained earnings	Treasury stock	TSR, Inc. equity	Non- controlling interest	Total
Balance at May. 31, 2022	$ 32,986	$ 7,473,866	$ 20,470,042	$ (13,514,003)	$ 14,462,891	$ 69,674	$ 14,532,565
Balance (in Shares) at May. 31, 2022	3,298,549
Net income attributable to noncontrolling interest						12,997	12,997
Non-cash stock compensation		69,216			69,216		69,216
Net income attributable to TSR, Inc.			494,746		494,746		494,746
Balance at Aug. 31, 2022	$ 32,986	7,543,082	20,964,788	(13,514,003)	15,026,853	82,671	15,109,524
Balance (in Shares) at Aug. 31, 2022	3,298,549
Balance at May. 31, 2022	$ 32,986	7,473,866	20,470,042	(13,514,003)	14,462,891	69,674	14,532,565
Balance (in Shares) at May. 31, 2022	3,298,549
Net income attributable to TSR, Inc.							1,248,219
Balance at Feb. 28, 2023	$ 33,226	7,666,711	21,718,261	(13,694,472)	15,723,726	38,485	15,762,211
Balance (in Shares) at Feb. 28, 2023	3,322,527
Balance at Aug. 31, 2022	$ 32,986	7,543,082	20,964,788	(13,514,003)	15,026,853	82,671	15,109,524
Balance (in Shares) at Aug. 31, 2022	3,298,549
Net income attributable to noncontrolling interest						13,055	13,055
Purchases of treasury stock				(116,426)	(116,426)		(116,426)
Non-cash stock compensation		69,216			69,216		69,216
Net income attributable to TSR, Inc.			673,833		673,833		673,833
Balance at Nov. 30, 2022	$ 32,986	7,612,298	21,638,621	(13,630,429)	15,653,476	95,726	15,749,202
Balance (in Shares) at Nov. 30, 2022	3,298,549
Net income attributable to noncontrolling interest						18,107	18,107
Distribution to noncontrolling interest						(75,348)	(75,348)
Purchases of treasury stock				(64,043)	(64,043)		(64,043)
Vested stock awards	$ 240	(240)
Vested stock awards (in Shares)	23,978
Non-cash stock compensation		54,653			54,653		54,653
Net income attributable to TSR, Inc.			79,640		79,640		79,640
Balance at Feb. 28, 2023	$ 33,226	7,666,711	21,718,261	(13,694,472)	15,723,726	38,485	15,762,211
Balance (in Shares) at Feb. 28, 2023	3,322,527
Balance at May. 31, 2023	$ 33,226	7,676,742	22,212,107	(13,726,895)	16,195,180	54,708	16,249,888
Balance (in Shares) at May. 31, 2023	3,322,527
Net income attributable to noncontrolling interest						24,876	24,876
Non-cash stock compensation		25,527			25,527		25,527
Net income attributable to TSR, Inc.			546,788		546,788		546,788
Balance at Aug. 31, 2023	$ 33,226	7,702,269	22,758,895	(13,726,895)	16,767,495	79,584	16,847,079
Balance (in Shares) at Aug. 31, 2023	3,322,527
Balance at May. 31, 2023	$ 33,226	7,676,742	22,212,107	(13,726,895)	16,195,180	54,708	16,249,888
Balance (in Shares) at May. 31, 2023	3,322,527
Net income attributable to TSR, Inc.							1,417,865
Balance at Feb. 29, 2024	$ 33,484	7,755,331	23,629,972	(13,726,895)	17,691,892	56,358	17,748,250
Balance (in Shares) at Feb. 29, 2024	3,348,361
Balance at Aug. 31, 2023	$ 33,226	7,702,269	22,758,895	(13,726,895)	16,767,495	79,584	16,847,079
Balance (in Shares) at Aug. 31, 2023	3,322,527
Net income attributable to noncontrolling interest						26,643	26,643
Non-cash stock compensation		25,527			25,527		25,527
Net income attributable to TSR, Inc.			459,985		459,985		459,985
Balance at Nov. 30, 2023	$ 33,226	7,727,796	23,218,880	(13,726,895)	17,253,007	106,227	17,359,234
Balance (in Shares) at Nov. 30, 2023	3,322,527
Net income attributable to noncontrolling interest						15,876	15,876
Distribution to noncontrolling interest						(65,745)	(65,745)
Vested stock awards	$ 258	(258)
Vested stock awards (in Shares)	25,834
Non-cash stock compensation		27,793			27,793		27,793
Net income attributable to TSR, Inc.			411,092		411,092		411,092
Balance at Feb. 29, 2024	$ 33,484	$ 7,755,331	$ 23,629,972	$ (13,726,895)	$ 17,691,892	$ 56,358	$ 17,748,250
Balance (in Shares) at Feb. 29, 2024	3,348,361

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Cash flows from operating activities:
Consolidated net income	$ 1,485,260	$ 1,292,378
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization	158,743	182,975
Unrealized (gain) loss on marketable securities, net	(9,288)	15,592
Deferred income taxes	65,000	493,000
Reversal of advances from customers	(547,318)
Non-cash lease recovery	(3,577)	(21,288)
Non-cash stock-based compensation expense	78,847	193,085
Changes in operating assets and liabilities:
Accounts receivable	1,546,207	1,848,999
Other receivables	26,183	841
Prepaid expenses	(186,711)	(103,859)
Prepaid and recoverable income taxes		14,737
Other assets	17,011	14,498
Accounts payable, other payables, accrued expenses and other current liabilities	238,818	(926,355)
Advances from customers	(131,179)
Income taxes payable	82,607	(13,622)
Legal settlement payable		(597,566)
Net cash provided by operating activities	2,820,603	2,393,415
Cash flows from investing activities:
Purchases of certificates of deposit	(500,000)	(990,000)
Maturities of certificates of deposit	990,000
Purchases of equipment and leasehold improvements		(6,317)
Net cash provided by (used in) investing activities	490,000	(996,317)
Cash flows from financing activities:
Net repayments on credit facility		(61,882)
Purchases of treasury stock		(180,469)
Distribution to noncontrolling interest	(65,745)	(75,348)
Net cash used in financing activities	(65,745)	(317,699)
Net increase in cash and cash equivalents	3,244,858	1,079,399
Cash and cash equivalents at beginning of period	7,382,320	6,490,158
Cash and cash equivalents at end of period	10,627,178	7,569,557
Supplemental disclosures of cash flow data:
Income taxes paid	344,000	121,000
Interest paid	$ 77,625	$ 61,000

Basis of Presentation

Basis of Presentation	9 Months Ended
	Feb. 29, 2024
Basis of Presentation [Abstract]
Basis of Presentation	1. Basis of Presentation The accompanying condensed consolidated interim financial statements include the accounts of TSR, Inc. and its subsidiaries. Unless otherwise stated or the context otherwise requires, the terms “we,” “us,” “our,” “TSR,” and the “Company” refer to TSR, Inc. and its subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of May 31, 2023, which has been derived from audited financial statements, and the unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America applying to interim financial information and with the instructions to Form 10-Q of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Accordingly, certain information and footnote disclosures required by accounting principles generally accepted in the United States of America and normally included in the Company’s annual financial statements have been condensed or omitted. These condensed consolidated interim financial statements as of and for the three months and nine months ended February 29, 2024 are unaudited; however, in the opinion of management, such statements include all adjustments (consisting of normal recurring adjustments) necessary to present fairly the consolidated financial position, results of operations, and cash flows of the Company for the periods presented. The results of operations for the interim periods presented are not necessarily indicative of the results that might be expected for future interim periods or for the full year ending May 31, 2024. These condensed consolidated interim financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended May 31, 2023. Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments – Credit Losses

Net Income Per Common Share

Net Income Per Common Share	9 Months Ended
	Feb. 29, 2024
Net Income Per Common Share [Abstract]
Net Income Per Common Share	2. Net Income Per Common Share Basic net income per common share is computed by dividing net income available to common stockholders of TSR by the weighted average number of common shares outstanding during the reporting period, excluding the effects of any potentially dilutive securities. During the quarters ended February 29, 2024 and February 28, 2021, the Company granted time and performance vesting restricted stock awards under the TSR, Inc. 2020 Equity Incentive Plan (the “Plan”) (see Note 12 for further information). Diluted earnings per share gives effect to all potentially dilutive common shares outstanding during the reporting period. The common stock equivalents associated with these restricted stock awards of 99,940 and 94,829 have been included for dilutive shares outstanding for the three and nine months ended February 28, 2023. There were no dilutive shares in the three and nine months ended February 29, 2024.

Cash and Cash Equivalents

Cash and Cash Equivalents	9 Months Ended
	Feb. 29, 2024
Cash and Cash Equivalents [Abstract]
Cash and Cash Equivalents	3. Cash and Cash Equivalents The Company considers short-term highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. Cash and cash equivalents were composed of the following as of February 29, 2024 and May 31, 2023: February 29, May 31, Cash in banks $ 4,631,170 $ 7,010,568 Certificates of deposit 2,548,161 - Money market funds 3,447,847 371,752 $ 10,627,178 $ 7,382,320

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Feb. 29, 2024
Fair Value of Financial Instruments [Abstract]
Fair Value of Financial Instruments	4. Fair Value of Financial Instruments Accounting Standards Codification (“ASC”) Topic 825, Financial Instruments

Certificates of Deposit and Mar

Certificates of Deposit and Marketable Securities	9 Months Ended
	Feb. 29, 2024
Certificates of Deposit and Marketable Securities [Abstract]
Certificates of Deposit and Marketable Securities	5. Certificates of Deposit and Marketable Securities The Company has characterized its investments in marketable securities, based on the priority of the inputs used to value the investments, into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and lowest priority to unobservable inputs (Level 3). If the inputs used to measure the investments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. Investments recorded in the accompanying condensed consolidated balance sheets are categorized based on the inputs to valuation techniques as follows: ● Level 1 - These are investments where values are based on unadjusted quoted prices for identical assets in an active market the Company has the ability to access. ● Level 2 - These are investments where values are based on quoted market prices that are not active or model derived valuations in which all significant inputs are observable in active markets. ● Level 3 - These are investments where values are derived from techniques in which one or more significant inputs are unobservable. The following are the major categories of assets measured at fair value on a recurring basis as of February 29, 2024 and May 31, 2023 using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3): February 29, 2024 Level 1 Level 2 Level 3 Total Equity Securities $ 34,440 $ - $ - $ 34,440 May 31, 2023 Level 1 Level 2 Level 3 Total Certificates of Deposit $ 490,000 $ - $ - $ 490,000 Equity Securities 25,152 - - 25,152 $ 515,152 $ - $ - $ 515,152 Based upon the Company’s intent and ability to hold its certificates of deposit to maturity (which range up to twelve (12) months at purchase), such securities have been classified as held-to-maturity and are carried at amortized cost, which approximates market value. The Company’s equity securities are classified as trading securities, which are carried at fair value, as determined by quoted market prices, which is a Level 1 input, as established by the fair value hierarchy. The related unrealized gains and losses are included in earnings. The Company’s marketable securities at February 29, 2024 and May 31, 2023 are summarized as follows: February 29, 2024 Amortized Gross Gross Recorded Equity Securities $ 16,866 $ 17,574 $ - $ 34,440 May 31, 2023 Amortized Gross Gross Recorded Certificates of Deposit $ 490,000 $ - $ - $ 490,000 Equity Securities 16,866 8,286 - 25,152 $ 506,866 $ 8,286 $ - $ 515,152 The Company’s investments in marketable securities consist primarily of investments in equity securities. Market values were determined for each individual security in the investment portfolio. When evaluating the investments for other-than-temporary impairment, the Company reviews factors such as length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, and the Company’s ability and intent to hold the investment for a period of time, which may be sufficient for anticipated recovery in market values.

Other Matters

Other Matters	9 Months Ended
	Feb. 29, 2024
Other Matters [Abstract]
Other Matters	6. Other Matters From time to time, the Company is party to various lawsuits, some involving material amounts. Management is not aware of any lawsuits that would have a material adverse impact on the consolidated financial position of the Company except for the litigation disclosed elsewhere in this report, included in Note 10 to the condensed consolidated financial statements.

Leases

Leases	9 Months Ended
	Feb. 29, 2024
Leases [Abstract]
Leases	7. Leases The Company leases the space for its offices in Hauppauge, New York and Edison, New Jersey. Under ASC 842, at contract inception we determine whether the contract is or contains a lease and whether the lease should be classified as an operating or finance lease. Operating leases are in right-of-use assets and operating lease liabilities are in our condensed consolidated balance sheets. The Company’s leases for its offices are classified as operating leases. The lease agreements for Hauppauge, New York and Edison, New Jersey expire on December 31, 2026 and May 31, 2027, respectively, and do not include any renewal options. In addition to the monthly base amounts in the lease agreements, the Company is required to pay real estate taxes and operating expenses during the lease terms. For the three months ended February 29, 2024 and February 28, 2023, the Company’s operating lease expense for these leases was $67,776 and $64,963, respectively. For the nine months ended February 29, 2024 and February 28, 2023, the Company’s operating lease expense for these leases was $204,684 and $213,845, respectively. As there are no explicit rates provided in our leases, the Company’s incremental borrowing rate was used based on the information available as of the commencement date in determining the present value of the future lease payments. Future minimum lease payments under non-cancellable operating leases as of February 29, 2024 are as follows: Twelve Months Ending February 29, 2025 $ 236,122 2026 242,590 2027 228,753 2028 32,527 Total undiscounted operating lease payments 739,992 Less imputed interest 89,922 Present value of operating lease payments $ 650,070 The following table sets forth the right-of-use assets and operating lease liabilities as of February 29, 2024: Assets Right-of-use assets, net $ 620,391 Liabilities Current operating lease liabilities $ 188,592 Long-term operating lease liabilities 461,478 Total operating lease liabilities $ 650,070 The weighted average remaining lease term for the Company’s operating leases is 3.1 years. The weighted average incremental borrowing rate was 8.42%

Credit Facility

Credit Facility	9 Months Ended
	Feb. 29, 2024
Credit Facility [Abstract]
Credit Facility	8. Credit Facility On November 27, 2019, TSR closed on a revolving credit facility (the “Credit Facility”) pursuant to a Loan and Security Agreement with Access Capital, Inc. (the “Lender”) which provides funding to TSR, Inc. and its direct and indirect subsidiaries, TSR Consulting Services, Inc., Logixtech Solutions, LLC and Eurologix, S.A.R.L., each of which, together with TSR, Inc., is a borrower under the Credit Facility. Each of the borrowers has provided a security interest to the Lender in all of their respective assets to secure amounts borrowed under the Credit Facility. TSR, Inc. expects to utilize the Credit Facility for working capital and general corporate purposes. The maximum amount that may be advanced under the Credit Facility at any time shall not exceed $2,000,000. Advances under the Credit Facility accrue interest at a rate per annum equal to (a) the “base rate” or “prime rate” announced by Citibank, N.A. from time to time, which shall be increased or decreased, as the case may be, in an amount equal to each increase or decrease in such “base rate” or “prime rate,” plus (b) 1.75%. The prime rate as of February 29, 2024 was 8.50%, indicating an interest rate of 10.25% on the line of credit. The initial term of the Credit Facility is five years, which shall automatically renew for successive five-year periods unless either TSR or the Lender gives written notice to the other of termination at least 60 days prior to the expiration date of the then-current term. TSR, Inc. is obliged to satisfy certain financial covenants and minimum borrowing requirements under the Credit Facility, and to pay certain fees, including prepayment fees, and provide certain financial information to the Lender. The Company was in compliance with all covenants at February 29, 2024. As of February 29, 2024, the net payments exceeded borrowings outstanding against this Credit Facility resulting in a receivable from the Lender of $43,484 which is included in “Other receivables” on the condensed consolidated balance sheets. The amount the Company has borrowed fluctuates and, at times, it has utilized the maximum amount of $2,000,000 available under the facility to fund its payroll and other obligations.

Intangible Assets

Intangible Assets	9 Months Ended
	Feb. 29, 2024
Intangible Assets [Abstract]
Intangible Assets	9. Intangible Assets The Company amortizes its intangible assets over their estimated useful lives and will review these assets for impairment when there is evidence that events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of these assets is measured by comparing the carrying amounts to the future undiscounted cash flows the assets are expected to generate. If intangible assets are considered to be impaired, the impairment to be recognized equals the amount by which the carrying value of the asset exceeds its fair market value. Intangible assets are as follows: May 31, February 29, 2023 Amortization 2024 Database (estimated life 5 years) $ 103,500 $ 34,500 $ 69,000 Trademark (estimated life 3 years) 5,000 5,000 - Customer relationships (estimated life 15 years) 1,225,000 75,000 1,150,000 Total $ 1,333,500 $ 114,500 $ 1,219,000 No instances of triggering events or impairment indicators were identified as of February 29, 2024.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Feb. 29, 2024
Related Party Transactions [Abstract]
Related Party Transactions	10. Related Party Transactions On January 5, 2021, the members of the Board of Directors of TSR, Inc. other than Robert Fitzgerald approved providing a waiver to QAR Industries, Inc. for its contemplated acquisition of shares owned by Fintech Consulting LLC under the Company’s prior Amended and Restated Rights Agreement so that a distribution date would not occur as a result of the acquisition. QAR Industries, Inc. and Fintech Consulting LLC were both principal stockholders of the Company, each owning more than 5% of the Company’s outstanding common stock prior to the consummation of the acquisition. Robert Fitzgerald is the President and majority stockholder of QAR Industries, Inc. The other directors of the Company are not affiliated with QAR Industries, Inc. On February 3, 2021, the acquisition was completed and QAR Industries, Inc. purchased 348,414 shares of TSR, Inc. common stock from Fintech Consulting LLC at a price of $7.25 per share. At the same time, Bradley M. Tirpak, Chairman of TSR, Inc., purchased 27,586 shares of the Company’s common stock from Fintech Consulting LLC at a price of $7.25 per share. On December 1, 2021, Fintech Consulting LLC (the “Plaintiff”) filed a complaint against the Company in the United States District Court for the District of New Jersey, related to the foregoing transaction. The named defendants in the complaint were the Company, QAR Industries, Inc., Robert E. Fitzgerald, a director and a stockholder of QAR Industries, Inc., and Bradley Tirpak (the “Defendants”). The complaint purported to assert claims against the Defendants under state law and Section 10(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) in connection with a Share Purchase Agreement, dated January 31, 2021, by and between the Plaintiff, as the seller of shares of the Company’s common stock, and QAR Industries, Inc. and Mr. Tirpak, as the purchasers of such shares (the “SPA”). The Plaintiff sought (i) judgment declaring the transactions represented by the SPA null and void and for the return of the shares; (ii) judgment cancelling the SPA and returning the shares in exchange for return of the purchase price; (iii) judgment unwinding the transaction; (iv) compensatory damages; (v) punitive damages; (vi) pre-judgment interest; (vii) costs of the lawsuit including attorneys’ fees; and (viii) such other relief as the Court may find appropriate. The Plaintiff filed its first amended complaint on March 2, 2022 which the Defendants moved to dismiss on April 19, 2022. On December 7, 2022, the court granted the Defendants’ motion and dismissed the New Jersey Action on jurisdictional grounds. Following the dismissal of the original lawsuit, the Plaintiff filed another complaint relating to the SPA against the Defendants on January 12, 2023, in the Court of Chancery of the State of Delaware (the “Delaware Chancery Action”), asserting claims and seeking relief substantially similar to that which was asserted and sought in the preceding lawsuit. The Delaware Chancery Action was dismissed without prejudice by the court on January 23, 2023. On January 22, 2023, the Plaintiff filed a complaint against the Company in the United States District Court for the District of Delaware (the “Delaware Federal Action”). The Delaware Federal Action, in sum and substance, asserted claims and sought relief substantially similar to that contained in both the New Jersey Action and the Delaware Chancery Action. Although the Company believed the Delaware Federal Action described above to be without merit, to avoid the time and expense of litigation, the Company negotiated with the Plaintiff to settle this matter pursuant to a settlement agreement and release dated April 24, 2023. An amount of $75,000 was paid in the fourth quarter of fiscal year 2023 to settle this matter. Upon the payment of the settlement amount (i) the Plaintiff forever released and discharged the Defendants from any and all claims or liability of any nature whatsoever; (ii) the Defendants forever released and discharged the Plaintiff from any and all claims or liability of any nature whatsoever that relate to the Delaware Federal Action or the SPA; and (iii) the Plaintiff filed a Stipulation of Dismissal with Prejudice on April 27, 2023. The Company has provided placement services for an entity in which a Board of Director of the Company is the former CEO. Revenues for such services were $8,600 in the three months ended February 29, 2024, and $35,000 in the three months ended February 28, 2023. Revenues for such services in the nine months ended February 29, 2024, and February 28, 2023 were approximately $25,400 and $70,800, respectively. There were no amounts outstanding as accounts receivable from this entity as of February 29, 2024 or February 28, 2023.

Common Stock

Common Stock	9 Months Ended
	Feb. 29, 2024
Common Stock [Abstract]
Common Stock	11. Common Stock Our certificate of incorporation, as amended, authorizes the issuance of up to 12,500,000 shares of common stock, $0.01 par value per share. On October 8, 2021, the Company filed an automatic shelf registration statement on Form S-3 (File No. 333-260152) (the “2021 TSRI Shelf”) which contains (i) a base prospectus, which covers the offering, issuance and sale by the Company of up to $5,000,000 in the aggregate of shares of common stock from time to time in one or more offerings; and (ii) a sales agreement prospectus, which covers the offering, issuance and sale by the Company of up to $4,167,000 in the aggregate of shares of common stock that may be issued and sold from time to time under an at-the-market sales agreement (the “2021 ATM”) by and between the Company and A.G.P./Alliance Global Partners, as sales agent (the “2021 Agent”). The $4,167,000 of common stock that may be offered, issued and sold under the sales agreement prospectus is included in the $5,000,000 of shares of common stock that may be offered, issued and sold by the Company under the base prospectus. Upon termination of the sales agreement, any portion of the $4,167,000 included in the sales agreement prospectus that is not sold pursuant to the sales agreement will be available for sale in other offerings pursuant to the base prospectus and if no shares are sold under the agreement, the full $4,167,000 of securities may be sold in other offerings pursuant to the base prospectus. Under the 2021 ATM, we pay the 2021 Agent a commission rate equal to 3.0% of the gross sales price per share of all shares sold through the 2021 Agent under the sales agreement. During the fiscal year ended May 31, 2022, we sold an aggregate of 142,500 shares of common stock pursuant to the 2021 ATM for total gross proceeds of $1,965,623 at an average selling price of $13.79 per share, resulting in net proceeds of $1,783,798 after deducting $181,825 in commissions and other transactions costs. There were no shares sold during the quarters or nine months ended February 29, 2024 and February 28, 2023. The 2021 TSRI Shelf is currently our only active shelf-registration statement. We may offer TSR, Inc. common stock registered under the 2021 TSRI Shelf from time to time in response to market conditions or other circumstances if we believe such a plan of financing is in the best interests of our stockholders. We believe that the 2021 TSRI Shelf provides us with the flexibility to raise additional capital to finance our operations as needed,.however, there is no assurance we will be successful in doing so.

Stock-Based Compensation Expens

Stock-Based Compensation Expense	9 Months Ended
	Feb. 29, 2024
Stock-Based Compensation Expense [Abstract]
Stock-based Compensation Expense	12. Stock-based Compensation Expense On January 28, 2021, the Company granted 108,333 shares in time vesting restricted stock awards and 69,167 shares in time and performance vesting restricted stock awards to officers, directors and key employees under the Plan. The time vesting shares vest in tranches at the one-, two- and three-year anniversaries of the grants (“service condition”). These shares had a grant date fair value of $826,000 based on the closing price of the Company’s common stock on the day prior to the grants. The associated compensation expense is recognized on a straight-line basis over the time between grant date and the date the shares vest (the “service period”). On January 29, 2024, the Company granted 69,167 shares in time and performance vesting restricted stock awards under the Plan. The time and performance vesting shares also vest in tranches at or after the two- and three-year anniversaries of the grants. The performance condition is defined in the grant agreements and relates to the market price of the Company’s common stock over a stated period of time (“market condition”). These 2021 and 2024 shares had grant date values of $262,000 and $300,000, respectively, based on the closing price of the Company’s common stock on the day prior to the grants discounted by an estimated forfeiture rate of 40-60%. The Company took into account the historical volatility of its common stock to assess the probability of satisfying the market condition. The associated compensation expense is recognized on a straight-line basis between the time the achievement of the performance criteria is deemed probable and the time the shares may vest. During the three months ended February 29, 2024 and February 28, 2023, $28,000 and $55,000, respectively, have been recorded as stock-based compensation expense and included in selling, general and administrative expenses. During the nine months ended February 29, 2024 and February 28, 2023, $79,000 and $193,000, respectively, have been recorded as stock-based compensation expense and included in selling, general and administrative expenses. As of February 29, 2024, there is approximately $290,000 of unearned compensation expense that will be expensed through January 2027; 34,333 stock awards expected to vest; 108,333 awards vested to date, of which 16,635 were forfeited to pay taxes applicable to the stock awards.

Stock Repurchase Program

Stock Repurchase Program	9 Months Ended
	Feb. 29, 2024
Stock Repurchase Program [Abstract]
Stock Repurchase Program	13. Stock Repurchase Program On September 12, 2022, the Board of Directors authorized a stock repurchase program of up to $500,000 of the Company’s outstanding common stock, par value $0.01 per share. The stock repurchase program commenced two business days after the filing of the related Form 8-K and is authorized for the twelve (12) months following the commencement date. The shares may be repurchased from time to time in open market transactions at prevailing market prices, in privately negotiated transactions, or by other means in accordance with federal securities laws. The actual timing, number and value of shares repurchased under the program will be determined by the Board of Directors at its discretion and will depend on a number of factors, including the market price of the Company’s stock, general market and economic conditions, and applicable legal and contractual requirements. The Company has no obligation or commitment to repurchase all or any portion of the shares covered by this authorization. During the three months and nine months ended February 28, 2023, 8,017 and 22,834 shares of the Company’s common stock were repurchased at an aggregate cost of $64,043 and $180,469, respectively. No shares were repurchased in the three months and nine months ended February 29, 2024.

Advances from Customers

Advances from Customers	9 Months Ended
	Feb. 29, 2024
Advances from Customers [Abstract]
Advances from Customers	14. Advances from Customers In January 2024, the New York State Office of Unclaimed Funds approved a Voluntary Disclosure Agreement (“VDA”) with the Company to resolve aged remittances received from customers that were not able to be reconciled and applied to invoices. These amounts have historically been carried as liabilities under the heading “Advances from Customers.” The process of identifying and remediating these payments where possible resulted in a payment to New York State of approximately $69,000. The approved VDA released the Company from liability for items aged beyond the scope of the ten year lookback period for items identified as New York based or unknown addresses. This resulted in the reversal of approximately $547,000 of these items from advances from customers. This amount is recorded as “Other Income” in the third quarter of fiscal 2024.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($)	3 Months Ended						9 Months Ended
	Feb. 29, 2024	Nov. 30, 2023	Aug. 31, 2023	Feb. 28, 2023	Nov. 30, 2022	Aug. 31, 2022	Feb. 29, 2024	Feb. 28, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 411,092	$ 459,985	$ 546,788	$ 79,640	$ 673,833	$ 494,746	$ 1,417,865	$ 1,248,219

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Feb. 29, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	9 Months Ended
	Feb. 29, 2024
Basis of Presentation [Abstract]
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated interim financial statements include the accounts of TSR, Inc. and its subsidiaries. Unless otherwise stated or the context otherwise requires, the terms “we,” “us,” “our,” “TSR,” and the “Company” refer to TSR, Inc. and its subsidiaries. All significant inter-company balances and transactions have been eliminated in consolidation. The condensed consolidated balance sheet as of May 31, 2023, which has been derived from audited financial statements, and the unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America applying to interim financial information and with the instructions to Form 10-Q of Regulation S-X of the Securities and Exchange Commission (the “SEC”). Accordingly, certain information and footnote disclosures required by accounting principles generally accepted in the United States of America and normally included in the Company’s annual financial statements have been condensed or omitted. These condensed consolidated interim financial statements as of and for the three months and nine months ended February 29, 2024 are unaudited; however, in the opinion of management, such statements include all adjustments (consisting of normal recurring adjustments) necessary to present fairly the consolidated financial position, results of operations, and cash flows of the Company for the periods presented. The results of operations for the interim periods presented are not necessarily indicative of the results that might be expected for future interim periods or for the full year ending May 31, 2024. These condensed consolidated interim financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended May 31, 2023.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments – Credit Losses

Cash and Cash Equivalents (Tabl

Cash and Cash Equivalents (Tables)	9 Months Ended
	Feb. 29, 2024
Cash and Cash Equivalents [Abstract]
Schedule of Cash and Cash Equivalents	The Company considers short-term highly liquid investments with original maturities of three months or less at the time of purchase to be cash equivalents. Cash and cash equivalents were composed of the following as of February 29, 2024 and May 31, 2023: February 29, May 31, Cash in banks $ 4,631,170 $ 7,010,568 Certificates of deposit 2,548,161 - Money market funds 3,447,847 371,752 $ 10,627,178 $ 7,382,320

Certificates of Deposit and M_2

Certificates of Deposit and Marketable Securities (Tables)	9 Months Ended
	Feb. 29, 2024
Certificates of Deposit and Marketable Securities [Abstract]
Schedule of Major Categories of Assets Measured at Fair Value on a Recurring Basis	The following are the major categories of assets measured at fair value on a recurring basis as of February 29, 2024 and May 31, 2023 using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3): February 29, 2024 Level 1 Level 2 Level 3 Total Equity Securities $ 34,440 $ - $ - $ 34,440 May 31, 2023 Level 1 Level 2 Level 3 Total Certificates of Deposit $ 490,000 $ - $ - $ 490,000 Equity Securities 25,152 - - 25,152 $ 515,152 $ - $ - $ 515,152
Schedule of Marketable Securities	The Company’s marketable securities at February 29, 2024 and May 31, 2023 are summarized as follows: February 29, 2024 Amortized Gross Gross Recorded Equity Securities $ 16,866 $ 17,574 $ - $ 34,440 May 31, 2023 Amortized Gross Gross Recorded Certificates of Deposit $ 490,000 $ - $ - $ 490,000 Equity Securities 16,866 8,286 - 25,152 $ 506,866 $ 8,286 $ - $ 515,152

Leases (Tables)

Leases (Tables)	9 Months Ended
	Feb. 29, 2024
Leases [Abstract]
Schedule of Future Minimum Lease Payments under Non-Cancellable Operating Leases	Future minimum lease payments under non-cancellable operating leases as of February 29, 2024 are as follows: Twelve Months Ending February 29, 2025 $ 236,122 2026 242,590 2027 228,753 2028 32,527 Total undiscounted operating lease payments 739,992 Less imputed interest 89,922 Present value of operating lease payments $ 650,070
Schedule of Right-Of-Use Assets and Operating Lease Liabilities	The following table sets forth the right-of-use assets and operating lease liabilities as of February 29, 2024: Assets Right-of-use assets, net $ 620,391 Liabilities Current operating lease liabilities $ 188,592 Long-term operating lease liabilities 461,478 Total operating lease liabilities $ 650,070

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Feb. 29, 2024
Intangible Assets [Abstract]
Schedule of Intangible Assets	Intangible assets are as follows: May 31, February 29, 2023 Amortization 2024 Database (estimated life 5 years) $ 103,500 $ 34,500 $ 69,000 Trademark (estimated life 3 years) 5,000 5,000 - Customer relationships (estimated life 15 years) 1,225,000 75,000 1,150,000 Total $ 1,333,500 $ 114,500 $ 1,219,000

Net Income Per Common Share (De

Net Income Per Common Share (Details) - shares	3 Months Ended	9 Months Ended
	Feb. 28, 2023	Feb. 28, 2023
Net Income Per Common Share [Line Items]
Restricted stock awards	99,940	94,829

Cash and Cash Equivalents (Deta

Cash and Cash Equivalents (Details) - Schedule of Cash and Cash Equivalents - USD ($)	Feb. 29, 2024	May 31, 2023
Schedule of Cash and Cash Equivalents [Abstract]
Cash in banks	$ 4,631,170	$ 7,010,568
Certificates of deposit	2,548,161
Money market funds	3,447,847	371,752
Total	$ 10,627,178	$ 7,382,320

Certificates of Deposit and M_3

Certificates of Deposit and Marketable Securities (Details) - Schedule of Major Categories of Assets Measured at Fair Value on a Recurring Basis - USD ($)	Feb. 29, 2024	May 31, 2023
Certificates of Deposit and Marketable Securities (Details) - Schedule of Major Categories of Assets Measured at Fair Value on a Recurring Basis [Line Items]
Marketable Securities		$ 515,152
Certificates of Deposit [Member]
Certificates of Deposit and Marketable Securities (Details) - Schedule of Major Categories of Assets Measured at Fair Value on a Recurring Basis [Line Items]
Marketable Securities		490,000
Equity Securities [Member]
Certificates of Deposit and Marketable Securities (Details) - Schedule of Major Categories of Assets Measured at Fair Value on a Recurring Basis [Line Items]
Marketable Securities	$ 34,440	25,152
Level 1 [Member]
Certificates of Deposit and Marketable Securities (Details) - Schedule of Major Categories of Assets Measured at Fair Value on a Recurring Basis [Line Items]
Marketable Securities		515,152
Level 1 [Member] | Certificates of Deposit [Member]
Certificates of Deposit and Marketable Securities (Details) - Schedule of Major Categories of Assets Measured at Fair Value on a Recurring Basis [Line Items]
Marketable Securities		490,000
Level 1 [Member] | Equity Securities [Member]
Certificates of Deposit and Marketable Securities (Details) - Schedule of Major Categories of Assets Measured at Fair Value on a Recurring Basis [Line Items]
Marketable Securities	34,440	25,152
Level 2 [Member]
Certificates of Deposit and Marketable Securities (Details) - Schedule of Major Categories of Assets Measured at Fair Value on a Recurring Basis [Line Items]
Marketable Securities
Level 2 [Member] | Certificates of Deposit [Member]
Certificates of Deposit and Marketable Securities (Details) - Schedule of Major Categories of Assets Measured at Fair Value on a Recurring Basis [Line Items]
Marketable Securities
Level 2 [Member] | Equity Securities [Member]
Certificates of Deposit and Marketable Securities (Details) - Schedule of Major Categories of Assets Measured at Fair Value on a Recurring Basis [Line Items]
Marketable Securities
Level 3 [Member]
Certificates of Deposit and Marketable Securities (Details) - Schedule of Major Categories of Assets Measured at Fair Value on a Recurring Basis [Line Items]
Marketable Securities
Level 3 [Member] | Certificates of Deposit [Member]
Certificates of Deposit and Marketable Securities (Details) - Schedule of Major Categories of Assets Measured at Fair Value on a Recurring Basis [Line Items]
Marketable Securities
Level 3 [Member] | Equity Securities [Member]
Certificates of Deposit and Marketable Securities (Details) - Schedule of Major Categories of Assets Measured at Fair Value on a Recurring Basis [Line Items]
Marketable Securities

Certificates of Deposit and M_4

Certificates of Deposit and Marketable Securities (Details) - Schedule of Marketable Securities - USD ($)	Feb. 29, 2024	May 31, 2023
Schedule of Marketable Securities [Abstract]
Amortized Cost, Equity Securities	$ 16,866	$ 16,866
Gross Unrealized Holding Gains, Equity Securities	17,574	8,286
Gross Unrealized Holding Losses, Equity Securities
Recorded Value, Equity Securities	$ 34,440	25,152
Total, Amortized Cost		506,866
Total, Gross Unrealized Holding Gains		8,286
Total, Gross Unrealized Holding Losses
Total, Recorded Value		515,152
Amortized Cost, Certificates of Deposit		490,000
Gross Unrealized Holding Gains, Certificates of Deposit
Gross Unrealized Holding Losses, Certificates of Deposit
Recorded Value, Certificates of Deposit		$ 490,000

Leases (Details)

Leases (Details) - USD ($)	3 Months Ended		9 Months Ended
	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Leases [Abstract]
Operating lease expense	$ 67,776	$ 64,963	$ 204,684	$ 213,845
Operating leases term	3 years 1 month 6 days		3 years 1 month 6 days
Weighted average incremental borrowing rate	8.42%		8.42%

Leases (Details) - Schedule of

Leases (Details) - Schedule of Future Minimum Lease Payments under Non-Cancellable Operating Leases	Feb. 29, 2024 USD ($)
Schedule of Future Minimum Lease Payments under Non-Cancellable Operating Leases [Abstract]
2025	$ 236,122
2026	242,590
2027	228,753
2028	32,527
Total undiscounted operating lease payments	739,992
Less imputed interest	89,922
Present value of operating lease payments	$ 650,070

Leases (Details) - Schedule o_2

Leases (Details) - Schedule of Right-of-Use Assets and Operating Lease Liabilities - USD ($)	Feb. 29, 2024	May 31, 2023
Assets
Right-of-use assets, net	$ 620,391	$ 459,171
Liabilities
Current operating lease liabilities	188,592	150,167
Long-term operating lease liabilities	461,478	$ 342,260
Total operating lease liabilities	$ 650,070

Credit Facility (Details)

Credit Facility (Details)	9 Months Ended
	Feb. 29, 2024 USD ($)
Credit Facility [Line Items]
Borrowed amount under credit facility	$ 2,000,000
Line of credit facility rate percentage	1.75%
Outstanding borrowings	$ 43,484
Prime Rate [Member]
Credit Facility [Line Items]
Line of credit facility rate percentage	8.50%
Credit Facility [Member]
Credit Facility [Line Items]
Borrowed amount under credit facility	$ 2,000,000
Prime Rate [Member]
Credit Facility [Line Items]
Interest rate of credit facility	10.25%

Intangible Assets (Details) - S

Intangible Assets (Details) - Schedule of Intangible Assets	9 Months Ended
	Feb. 29, 2024 USD ($)
Finite-Lived Intangible Assets [Line Items]
Intangible assets, beginning	$ 1,333,500
Amortization	114,500
Intangible assets, ending	1,219,000
Database [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, beginning	103,500
Amortization	34,500
Intangible assets, ending	69,000
Trademark [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, beginning	5,000
Amortization	5,000
Intangible assets, ending
Customer relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible assets, beginning	1,225,000
Amortization	75,000
Intangible assets, ending	$ 1,150,000

Intangible Assets (Details) -_2

Intangible Assets (Details) - Schedule of Intangible Assets (Parentheticals)	Feb. 29, 2024
Database [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated life	5 years
Trademark [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated life	3 years
Customer relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Estimated life	15 years

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)			3 Months Ended		9 Months Ended
	Feb. 03, 2021	Jan. 05, 2021	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Related Party Transactions [Line Items]
Outstanding owned percent of common stock		5%
Purchase of shares (in Shares)				8,017		22,834
Paid amount					$ 75,000
Revenue			$ 19,702,992	$ 24,257,167	63,873,759	$ 76,487,411
TSR, Inc [Member]
Related Party Transactions [Line Items]
Purchase of shares (in Shares)	27,586
Chief Executive Officer [Member]
Related Party Transactions [Line Items]
Revenue			$ 8,600	$ 35,000
Board of Directors Chairman [Member]
Related Party Transactions [Line Items]
Revenue					$ 25,400	$ 70,800
QAR Industries, Inc. [Member]
Related Party Transactions [Line Items]
Purchase of shares (in Shares)	348,414
Fintech Consulting LLC [Member]
Related Party Transactions [Line Items]
Price per share (in Dollars per share)	$ 7.25
Fintech Consulting LLC [Member] | TSR, Inc [Member]
Related Party Transactions [Line Items]
Price per share (in Dollars per share)	$ 7.25

Common Stock (Details)

Common Stock (Details) - USD ($)		12 Months Ended
	Oct. 08, 2021	May 31, 2022	Feb. 29, 2024	May 31, 2023
Common Stock [Line Items]
Common stock, shares authorized (in Shares)			12,500,000	12,500,000
Common stock par value per share (in Dollars per share)			$ 0.01	$ 0.01
Issuance of aggregate shares	$ 5,000,000
Sold of securities shares	$ 4,167,000
Commission rate equal percentage	3%
Aggregate shares (in Shares)		142,500
Gross proceeds		$ 1,965,623
Selling price of per share (in Dollars per share)		$ 13.79
Net proceeds		$ 1,783,798
Commissions and other transactions costs		$ 181,825
Common Stock [Member]
Common Stock [Line Items]
Common stock par value per share (in Dollars per share)			$ 0.01
Sales Agreement [Member]
Common Stock [Line Items]
Issuance of aggregate shares	$ 4,167,000
Prospectus [Member]
Common Stock [Line Items]
Issuance of aggregate shares	5,000,000
Sold of securities shares	4,167,000
Alliance Global Partners [Member]
Common Stock [Line Items]
Issuance of aggregate shares	$ 4,167,000

Stock-Based Compensation Expe_2

Stock-Based Compensation Expense (Details) - USD ($)			3 Months Ended		9 Months Ended
	Jan. 29, 2024	Jan. 28, 2021	Feb. 29, 2024	Feb. 28, 2023	Feb. 29, 2024	Feb. 28, 2023
Stock-Based Compensation Expense [Line Items]
Granted shares (in Shares)		108,333
Vesting restricted stock awards		$ 69,167
Grant date fair value		$ 826,000
Granted shares (in Shares)	69,167				34,333
Stock-based compensation expense			$ 28,000	$ 55,000	$ 79,000	$ 193,000
Compensation expense					$ 290,000
Shares vested (in Shares)					108,333
Forfeited shares (in Shares)					16,635
Minimum [Member]
Stock-Based Compensation Expense [Line Items]
Grant date fair value					$ 262,000
Estimated forfeiture rate					40%
Maximum [Member]
Stock-Based Compensation Expense [Line Items]
Grant date fair value					$ 300,000
Estimated forfeiture rate					60%

Stock Repurchase Program (Detai

Stock Repurchase Program (Details) - USD ($)	3 Months Ended	9 Months Ended
	Feb. 28, 2023	Feb. 28, 2023	Feb. 29, 2024	May 31, 2023	Sep. 12, 2022
Stock Repurchase Program [Line Items]
Common stock, par value (in Dollars per share)			$ 0.01	$ 0.01
Shares repurchased shares (in Shares)	8,017	22,834
Repurchased stock value	$ 64,043	$ 180,469
Board of Directors [Member]
Stock Repurchase Program [Line Items]
Stock repurchase program value					$ 500,000
Common stock, par value (in Dollars per share)					$ 0.01

Advances from Customers (Detail

Advances from Customers (Details) - USD ($)	Jan. 31, 2024	Feb. 29, 2024	May 31, 2023
Advances from Customers [Abstract]
Payment to new york state	$ 69,000
Customer advances	$ 547,000	$ 588,496	$ 1,266,993